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Gelsemium sempervirens is used in homeopathy for treating patients with anxiety related symptoms, however there have been
few experimental studies evaluating its pharmacological activity. We have investigated the eﬀects of homeopathic doses of G.
sempervirens on mice, using validated behavioral models. Centesimal (CH) dilutions/dynamizations of G. sempervirens,t h e
reference drug diazepam (1mg/kg body weight) or a placebo (solvent vehicle) were intraperitoneally delivered to groups of mice of
CD1strainduring8days,thentheeﬀectswereassessedbytheLight-Dark(LD)choicetestandbytheOpen-Field(OF)exploration
test,inafullyblindmanner.IntheLDtest,themeantimespentintheilluminatedareabycontrolandplacebo-treatedanimalswas
15.98%,formicetreatedwithdiazepamitincreasedto19.91%(P =.047),whilewithG.sempervirens5CHitwas18.11%(P =.341,
non-signiﬁcant). The number of transitions between the two compartments increased with diazepam from 6.19 to 9.64 (P < .001)
but not with G. Sempervirens. In the OF test, G. sempervirens 5 CH signiﬁcantly increased the time spent and the distance traveled
in the central zone (P = .009 and P = .003, resp.), while diazepam had no eﬀect on these OF test parameters. In a subsequent series
of experiments, G. sempervirens 7 and 30 CH also signiﬁcantly improved the behavioral responses of mice in the OF test (P <
.01 for all tested variables). Neither dilutions of G. sempervirens aﬀected the total distance traveled, indicating that the behavioral
eﬀect was not due to unspeciﬁc changes in locomotor activity. In conclusion, homeopathic doses of G. sempervirens inﬂuence
the emotional responses of mice to novel environments, suggesting an improvement in exploratory behavior and a diminution of
thigmotaxis or neophobia.
1.Introduction
In homeopathic Materia Medica, Gelsemium sempervirens
(Loganaceae) is described as a remedy for a variety of
neurological and behavioral symptoms including general
prostration, drowsiness, tiredness, mental apathy, lack of
muscular coordination and discomfort when confronted
with novelty or unfamiliar situations; these symptoms
are alleviated by motion and aggravated by emotion and
excitement [1–3]. However there have been only a few exper-
imental studies supporting this assertion [4]. Therefore,
there is scope for testing this compound in homeopathic
dilutions on validated behavioral models of emotional state
and anxiety. G. sempervirens is a twining vine native to warm
temperate and tropical America, from Guatemala north
to the southeastern USA. All parts of this plant contain
the toxic strychnine-related alkaloids gelsemine, gelseminine
and sempervirine [5]. Neurological signs characterized by
marked progressive weakness and convulsions culminating
in death have been observed in goats after ingestion of G.
sempervirens and ensuing toxicosis [6]. At pharmacological
doses, G. sempervirens has been reported to show sedative,
analgesic and anti-seizure properties [7–9]. In an early
report [10], ultra-low doses of G. sempervirens in mice were
found to counter the behavioral eﬀects of the anxiogenic
compoundRO15-3505(inverseagonistofbenzodiazepines).
More recently, Bousta et al. report that in some but not
all experimental conditions, homeopathic dilutions of G.
sempervirens reduce stress-induced behavioral alterations
of mice in the staircase and light-dark (LD) tests [11].
However, these results consist of reversing the eﬀects of
severe stress (conditioned paradigm), and the ﬁndings
vary widely depending on the dose administered and test
performed.2 Evidence-Based Complementary and Alternative Medicine
In this article we report a series of experiments testing
the possible eﬀects on mouse behavioral responses to G.
sempervirens in homeopathic dilutions/dynamizations. Two
validated tests on animal models, namely the LD choice
test and the open-ﬁeld (OF) test, were used in order
to acquire various behavioral parameters widely used in
neuropsychopharmacology for drug screening [12–14]. We
performed the study on the unconditioned responses, using
ethologically based paradigms which involve the sponta-
neous reactions to non-painful stimuli. The LD test is
based on the innate aversion of rodents to brightly lit area:
control mice placed in the large, bright, section will rapidly
move into the dark chamber and a classic anxiolytic eﬀect
manifests itself as an increase in the percentage of time
spent in the light area and in the number of transitions
between the two compartments [15]. The OF test involves
placing an animal in an unknown environment in order to
observe a number of behavior patterns. The tendency to stay
on the periphery of the ﬁeld is known as thigmotaxis and
is often considered an index of highly emotional behavior
[16, 17]. Conversely, the percentage of time spent in the
central zone and the distance traveled in the central zone
are considered indicative of exploratory behavior and should
reﬂect a decrease in anxiety.
In homeopathy, a wide range of dosages are used. Such
formulations are better described as homeopathic dilutions
(also called “dynamizations”, or “potencies”), whose prepa-
ration procedure involves successive steps of dilution—
10× or Decimal (D), 100× or Centesimal (CH)—followed
by strong manual or mechanical succussion. Homeopathic
dilutions/dynamizations such as 5 CH are expected to
contain ultra-low concentrations of the purported active
ingredient, but in amounts still within the molecular range
since the dilution factor from the ﬁrst ethanolic extract
(mother tincture) is 1010. In this work we chose to start the
investigation with a series of experiments testing the eﬀects
of the 5 CH dilution/dynamization, which is currently used
not only in homeopathic therapy but is also in the domain
of “conventional” pharmacology and of current scientiﬁc
wisdom. Since homeopathy also makes use of high dilu-
tions/dinamizations, in an ensuing series of experiments, we
investigated the eﬀects of further dilutions/dynamizations,
namely G. sempervirens 7 and 30 CH.
2. Methods
2.1. Subjects and Maintenance. Male 4-5-week-old mice
of the speciﬁed inbred strains (CD1 or C57BL/J6) were
purchased from Harlan Laboratories (Udine, I) and allowed
t oa c c l i m a t ef o r1w e e kb e f o r et e s t i n g .M i c ew e r er a n d o m l y
distributed 4/cage in standard polycarbonate cages (369 ×
156 × 132mm) with water and food available ad libitum,i n
an air-conditioned room (temperature 22 ±2
◦C, humidity
∼55 ± 5%). Lights were left switched on between 7 a.m. and
7 p.m. Cages were cleaned and bottles were ﬁlled with fresh
tap water thrice a week, excluding on the days of testing.
The sequential order in which mice were injected and then
tested was arranged so that the mean interval time between
injection and testing was the same for all the experimental
groups. G. sempervirens and the control vehicle (placebo)
were administered intraperitoneally (i.p.) each day at 9 a.m.
for 9 consecutive days, including on the 2 last days devoted
to behavioral testing. Mice belonging to the benzodiazepine
standard treatment group were also injected with the control
solution for 9 days, but on the testing days the control
solution was supplemented with diazepam (see below).
Apart from the drug injections and testing, the animals
were not subjected to pain or other forms of emotional or
physical stress. The animals were used only once in any given
test to avoid the confounding eﬀects of learning and habit-
uation. After completing the tests, the mice were put back
intotheiroriginalhomecagesandthensacriﬁcedusingCO2-
saturated atmosphere. All the tests were conducted at the
Faculty of Medicine, Verona University, Italy, in accordance
with the guidelines approved by the European Community
Council Directive of November 24, 1986 (law86/609/CEE).
The testing procedures were approved by the Animal Ethical
CommitteeoftheVeronaUniversityandbytheItalianHealth
Ministry (authorization n. 4 Tit. VII/5, February 16, 2007).
2.2. Drugs. Gelsemium sempervirens in the 4, 6 and 29
CH dilutions/dynamizations was prepared by Boiron Lab-
oratories (Lyon, F) from the mother tincture of plant
roots, according to the French Pharmacopoeia [18]a n d
supplied as a hydroalcoholic (30% ethanol, v/v) solution.
The mother tincture was assayed to determine its gelsemine
content, which proved to be 0.021%; since the molecular
weight of this compound is 322.41, its concentration in
the mother tincture used for preparing the homeopathic
dilutions/dynamizations was 6.5 ×10
−4 moles/l. The control
solution (placebo) used in this investigation was provided
by Boiron Laboratories, using the same hydroalcoholic
solvent stock (30% ethanol, v/v) employed to prepare the G.
sempervirens dilutions. On the morning of the ﬁrst day of
drug delivery, before starting the treatment, 0.4ml samples
of the solutions were added to 39.6ml of distilled sterile and
apyrogenic water in a sterile 50ml Falcon plastic tube, closed
with a plastic cap and the dilution was manually succussed
with 20 strong vertical strokes to obtain the operative
dilutions 5, 7 and 30 CH, with ﬁnal ethanol concentration
lowered to 0.3% (v/v). Since each dilution step involves a 100
×decreaseinconcentration,the“theoretical”concentrations
ofgelsemineinthe5,7and30CHsolutionswere6.5×10
−14,
6.5×10
−18 and6.5×10
−64 moles/l,respectively.Theoperators
who performed the injections and the behavioral tests were
totally unaware (“blind”) of the treatment group to which
the animals had been assigned. Blinding of all procedures
of injection and testing was performed by randomizing and
coding the tubes containing the drug and control solutions.
The person who coded the solutions did not belong to
the research group and signed a conﬁdentiality agreement
form; the codes were recorded on a sheet that was kept
sealed inside an envelope until all the tests and calculations
were completed. The coded solutions were distributed in
15ml sterile Falcon plastic tubes (7.5ml/tube), wrapped in
aluminumfoilandstoredat+4◦Cuntilthedayofuse.Before
administering the contents, each tube was manually shaken
with 20 strokes. On the days of the behavioral tests, the miceEvidence-Based Complementary and Alternative Medicine 3
were injected 60 min before the start of the tests, which
were performed between 11 a.m. and 3 p.m. Each day, 0.3ml
of the remedy or control placebo were administered by i.p.
injection using 1ml insulin syringes. The benzodiazepine
standard drug was diazepam (Valium,R o c h e )( 5 m g / m l ) ,
diluted by an independent investigator to ensure blinding
of operators with respect to group assignment, in the same
control solution and administered intraperitoneally at the
ﬁnal dose of 1mg/kg body weight (b.w.).
2.3. Behavior Assessment. A video-tracking camera (GZ-
MG135, JVC, Japan) and a software program (“Smart” VTS
system from PanLab, Barcelona, E) were used to record the
sessions automatically. The camera viewed four test arenas,
each one of which, in turn, was divided by the software into
two diﬀerent zones according to the test to be performed
(LD or OF). All the sessions were recorded and stored as
DVD.Thevideooutcomesignalswereconvertedthroughthe
imageprocessorintobinaryimagesinsuchamannerthatthe
animal was tracked as a black spot with a white background.
The movement of the spot was recorded to track the position
of the animals, the time they stayed in diﬀerent zones and
the distance traveled. The number of transitions between
light and dark compartments in the LD test was evaluated
on the video by an operator who was unaware of the group
assignment of the mice.
The experiments were performed on each group of
animals in the following order: LD choice test on day one
(8th day of drug administration) and OF exploration test
on the following day (9th day of drug administration). Mice
were tested individually in each test arena and the operators
stayed outside the testing room during the recording of the
experimental session. Just before testing, the animals were
allowed to acclimate to the room inside their cages for 3 min
after being moved from their usual housing area.
The LD test arena consisted of two interconnected
compartments that diﬀered in size and color: a white open
square (30cm × 30cm) and a black covered compartment
(30cm × 15cm). Both compartments had walls that were
25cm high. A small opening (4 × 4cm) allowed the mice
to freely move from the illuminated to the dark chamber and
vice versa. The white ﬁeld was brightly lit at 200 lux and the
mice were left to explore the space for a 5 min testing period.
The OF test arena consisted of a 50 × 50cm wooden
platform, painted black and enclosed by 25cm high walls.
White light (100 lux) was present in the room. The 10 min
test began with the subject being placed inside the OF arena,
in a corner near the walls. Using the video-tracking system,
thearenawasvirtuallydividedtodeﬁneasquarecentralzone
occupying 25% of the total area. The tendency to enter the
central zone and to travel inside it, instead of running along
the walls or staying in the corners, is considered to be a sign
of a decrease in the anxiety induced by a novel environment
(neophobia) and of an increase in exploratory attitude,
typical of mice that consider the experimental setting to be
familiar. Thigmotaxis is particularly apparent upon the ﬁrst
exposure to a novel space, and helps the animal to deﬁne the
boundaries of an unfamiliar environment. In unconditioned
behavior tests in which an animal is placed for the ﬁrst time
in an arena, it also reﬂects novelty induced anxiety, general
activity, exploratory behavior and decision-making [12].
2.4.Statistics. Intheﬁrstseriesofexperiments,thedatafrom
ﬁve experiments performed on three treatment groups of
mice, which received either the 5 CH dilution or diazepam
or a control placebo (total of ﬁve experiments = 72 mice per
treatment group) were pooled and analyzed. In the second
series of experiments, the data from one experiment per-
formed on three treatment groups of mice, which received
either the 5 or the 7 CH dilution or the placebo (total = 16
mice per treatment group) and those from two experiments
performed with four treatment groups of mice, which
received either the 5 CH or the 7 CH or the 30 CH dilutions
or the placebo (total = 32 mice per treatment group) were
pooled and analyzed. Extreme behavioral responses were
considered as outlier data and excluded when their value
exceeded 2 standard deviations (SDs). This occurred in very
few cases (see Results section). When the distribution of
data was normal (data from OF tests), the groups were
compared by two-way analysis of variance (ANOVA SPSS,
version 11 for Windows, Chicago, IL), using the treatment
group and the experiments as the factors. The latter factor
was included in the ANOVA analysis because the control
values of activity varied considerably between experiments.
Post-hoc t-tests were performed assuming equal variances
with least signiﬁcant diﬀerence (LSD) corrections to adjust
for multiple comparisons. When the distribution was not
normal (data from LD tests), the groups were compared by
the non-parametric Kruskal-Wallis analysis of variance test,
followed by the Mann–Whitney test for two independent
samples to determine whether the activities of the control
and drug-treated groups diﬀered from each other.
The eﬀect of the drugs on the various behavioral
parameters was also calculated as a percentage with respect
to the control values (taken as 100%) for each experiment,
according to the formula:
Activity of each drug-treated animal/mean activity of
control animals × 100.
This allowed the eﬀects of the various dilutions tested in
the two series of experiments, standardized as a percentage
of their internal control values for untreated animals, to be
compared and statistically evaluated.
3. Results
3.1. LD Choice. Table 1 reports the mouse behavior data in
the LD test, in terms of the two main parameters: percentage
of time spent in the illuminated area and the number of
transitions between the two compartments. The mean time
spentbycontrol(placebo-treated)animalsintheilluminated
area was 15.98%, for mice treated with G. sempervirens
5 CH it was 18.11% (non-signiﬁcant), while diazepam
instead signiﬁcantly increased the mean time spent in the
illuminated compartmentto 19.91% (P =.047).The number
of transitions between the two compartments increased little
in the G. sempervirens 5 CH-treated group, while in the
diazepam-treated group the values rose from a mean of 6.19
(control) to a mean of 9.64 (P < .001).4 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀects of G. sempervirens 5 CH and diazepam on the behavioral parameters in the LD.
Parameter Control G. sempervirens (5 CH) Diazepam
n Mean SEM n Mean SEM Pa n Mean SEM Pa
Percentage of time in light∗ 71 15.98 1.29 69 18.11 1.42 .341 69 19.91 1.39 .047
Number of transitions∗∗ 71 6.19 0.58 70 6.40 0.56 .699 70 9.64 0.64 <.001
aMann—Whitney test of treated group versus control.
∗Kruskal Wallis for groups P = .159.
∗∗Kruskal Wallis for groups P<. 001.
Table 2: Eﬀects of G. sempervirens 5 CH and diazepam on the behavioral parameters in the OF test.
Parameter Control G. sempervirens (5 CH) Diazepam
n Mean SEM n Mean SEM Pa n Mean SEM Pa
Percentage of time in center∗ 69 6.34 0.41 70 7.86 0.41 .009 69 6.21 0.48 .812
Distance in center∗∗ 68 589.9 37.8 70 738.9 38.0 .003 68 585.1 49.5 .925
Total distance a∗∗∗ 70 5181.5 166.2 71 5371.4 168.1 .306 71 5321.7 211.1 .449
aPost-hoc analysis of treated group versus control.
Two-way ANOVA for groups: ∗P <. 001, ∗∗P = .001, ∗∗∗P = .647.
For experiments ∗P <. 001, ∗∗P = .001, ∗∗∗P <. 001.
3.2. OF Exploration. Table 2 reports the results for the OF
tests.Theplacebo-treatedcontrolanimalsspent6.34%ofthe
time in the center of the OF arena. This value is considerably
<25% one would expect in the case of a random choice,
indicating that the central zone was quite uncomfortable for
themice.IntheG.sempervirens5CH-treatedgroup,thetime
spent in the central zone of the arena increased to 7.86%
(P = .009), while the action of diazepam in this test was
totallyineﬀective.Thedistancetraveledbymiceinthecentral
zone of the arena was also positively inﬂuenced by treatment
with G. sempervirens 5 CH, with an overall mean increase
from 589.9 to 738.9cm (P = .003). During the OF test the
total distance traveled by the mice in the entire arena was
alsoanalyzed.Nosigniﬁcanteﬀectwasfoundindrug-treated
versus placebo-treated animals, indicating that the observed
diﬀerences in time and distance spent in the central zone
werenotduetochangesinthegeneral,unspeciﬁc,locomotor
activity of the mice.
The weight of the animals before and after the treatment
was similar in the three treatment groups, suggesting no
diﬀerences in feeding, metabolism or growth attributable
to drug eﬀects (data not shown). There was found to be
a signiﬁcant diﬀerence between the mean values for the
ﬁve experiments (see notes to Tables 1 and 2), which was
taken into account to control for its possible confounding
eﬀects. Finally, no signiﬁcant interactions between groups
and experiments were noted.
3.3. Study of a Diﬀerent Mice Strain. We also performed
one experiment in which the G. sempervirens 5 CH dilu-
tion/dynamization was tested on a diﬀerent strain of mouse,
C57BL. This yielded results qualitatively similar to those
for the CD1 mice in both test models, conﬁrming an
increase in the time spent and distance traveled in the center
of the OF induced by G. sempervirens 5C H .H o w e v e r ,
due to the variability of responses between animals, the
diﬀerences between control- and G. sempervirens-treated
groups (e.g., 6.11 ± 0.80 and 8.83 ± 1.38% time spent in the
center, respectively) in this individual experiment were not
statistically signiﬁcant (P = .068).
3.4. Even High Dilutions Work Better than Placebo. Follow-
ing these positive results obtained with the 5 CH dilu-
tion/dynamization,weperformedthreefurtherexperiments,
using the same protocol to also test higher dilutions, namely
G. sempervirens 7 and 30 CH, in addition to 5 CH and
a control placebo. Diazepam was not included here to
avoid needlessly sacriﬁcing animals, since the results for this
control drug were suﬃciently clear from the ﬁrst series of
experiments. The 5 and 7 CH dilutions/dynamizations of
G. sempervirens were ineﬀective in the LD test; the 30 CH
dilution slightly increased the values of the LD parameters,
especially the number of transitions, but these eﬀects were
not statistically signiﬁcant (data not shown). In the OF test
(Table 3), the percentage time spent in the center of the
arena and the distance traveled in the center were increased
by all the G. sempervirens dilutions/dynamizations, with
highly statistically signiﬁcant results using the 7 and the 30
CH dilutions/dynamizations (P < .01). The eﬀect of the 5
CH dilution/dynamization was quantitatively similar to that
previously described in Table 2, but in these experiments it
did not reach the statistical signiﬁcance threshold, due to
the lower size of subject population and to high inter-subject
data variability (SEM). The maximum and most signiﬁcant
eﬀectwasobtainedintheOF(distancetraveledinthecenter)
with the 30 CH dilution/dynamization (P = .002). In this
series of experiments, too, the tested dilutions were found
to have no signiﬁcant eﬀect on the unspeciﬁc locomotor
activity, as indicated by the total distance traveled in the
arena.
3.5. Summary of All the Experimental Data. A summary of
the main results of this investigation is given in Figure 1.
The mean percentage values for all the mice of the treatedEvidence-Based Complementary and Alternative Medicine 5
Table 3: Eﬀects of G. sempervirens 5, 7 and 30 CH on the behavioral parameters in the OF testa.
Parameter
Control G. sempervirens (5 CH) G. sempervirens (7 CH) G. sempervirens (30 CH)
n Mean SEM n Mean SEM Pb n Mean SEM Pb n Mean SEM Pb
Percentage of
time in center∗ 47 5.98 0.51 48 7.09 0.61 .169 47 8.19 0.52 .007 32 8.60 0.80 .004
Distance in
center∗∗ 45 501.1 42.6 48 618.5 46.6 .089 47 702.6 41.3 .004 32 744.0 75.1 .002
Total
distance∗∗∗ 47 4892.9 167.6 47 5180.3 146.4 .183 46 5248.7 171.7 .102 31 5158.1 235.4 .378
aData are pooled from three experiments (control, 5 CH and 7 CH) and from two experiments (30 CH).
bPost-hoc analysis of treated group versus control.
Two-way ANOVA for groups: ∗P = .012, ∗∗P = .008, ∗∗∗P = .371. For experiments ∗P = .075, ∗∗P = .867, ∗∗∗P <. 001.
groups conﬁrms the increase due to diazepam but not due
to G. sempervirens dilutions in the LD paradigm (panels (a)
and (b)) and the signiﬁcant increase due to all the tested
homeopathic dilutions/dynamizations of G. sempervirens in
the OF-tested variables (panels (c) and (d)).
4. Discussion
In the ﬁeld of psychopathology, animal models have become
an invaluable tool for analyzing the mechanisms of various
disorders, and have aided in developing and predicting
therapeutic responses to pharmacological agents such as
benzodiazepines. In this work we investigated the eﬀects
of Gs . sempervirens on the non-conditioned behavior of
mice, using two widely validated models that allow the
expression of various “symptoms” of emotional responses.
Weusedethologicalmodelsinwhichtheanimalisinﬂuenced
by emotional states of fear, curiosity or anxiety induced
under diﬀerent test paradigms without further conditioning,
thus allowing for comprehensive “behavioral proﬁling”.
Traditional diﬃculties in accepting these models stem from
the argument that there is no conclusive evidence that what
occurs in animals is equivalent to what occurs in humans.
On the other hand, most conventional drugs and, recently,
several homeopathic medicines have been tested in animal
models, whose main advantages are that they allow multiple
testing under controlled conditions and easier access to
studying the mechanism of drug(s) activity.
4.1. Diﬀerent Symptoms Modulation According to the Model.
Most behavioral procedures for studying the pharmacology
of anxiety use models involving non-conditioned behavior,
that are usually based on novelty induced variations in
exploratory activity. Considering the LD model, diazepam
wasactive,asexpected,signiﬁcantlyincreasingthetimespent
in the light arena and the number of transitions. In the same
assays, G. sempervirens w a sm u c hl e s sa c t i v et h a nt h ec o n -
ventional anxiolytic drug. Our data, showing small, but not
signiﬁcant, eﬀects of G. sempervirens in the LD model, are in
agreementwiththoseofBoustaetal.[11]whoreportedsome
anxiolytic-like eﬀects in mice stressed by repeated electric
shock, but no eﬀects in normal mice. Diﬀerences between
the type and severity of external stressors or the animal
strain or in the experimental setup might account for the
high variability of results reported in diﬀerent experimental
conditions and by diﬀerent laboratories [21, 22]. It has been
noted that the extent to which an anxiolytic compound can
facilitate exploratory activity depends on its baseline level in
the control group [23]. Since our experimental setting did
not involve prior exposure to stress, it is conceivable that in
those conditions the response of the mice to G. sempervirens
was slight because the level of basal anxiety, assessed by LD
choice, was low.
In the OF model, all dilutions/dynamizations of G.
sempervirens changed the behavior of the mice, reducing
thigmotaxis, an anxiety-like behavioral response. The eﬀects
of G. sempervirens on the tendency of animals to stay
and move in the center of the OF arena rather than in
the periphery was consistent in the diﬀerent experiments
and highly statistically signiﬁcant. Thigmotaxis is a very
conspicuous behavior in anxious animals, and plays a role
in the formation of avoidance behavior and cognition. It is
therefore a primordial behavior, with a genetic basis, that
is ecologically important and used by both animals and
humans for exploring the environment.
The ﬁnding of a drug-induced increase in the distance
traveled in the center of the arena, but not in the total
distance traveled, suggests that the eﬀects of G. sempervirens
in our model system are anxiolytic rather than sedative
or otherwise aﬀecting animal locomotion. Since we used a
control vehicle as a placebo in all experiments, the eﬀects
cannot be attributed to the very low dose of ethanol
present in the ﬁnal operating solutions, unlike in certain
previous studies where the use of alcohol as vehicle for
homeopathic preparations might have been able to produce
some background eﬀects in behavioral tests [24]. A further
methodological issue that reinforces our ﬁndings is the
systematic use of blinding, a procedure rarely employed in
animal research, but which is worthwhile especially when
testing hypotheses that are apparently in contrast with
conventional scientiﬁc wisdom, such as the very existence of
biological activity of solutions diluted beyond the Avogadro
limit.
Since the reference benzodiazepine drug was inactive
in the OF test, the results indicate that, at least in our
experimental conditions, OF and LD explore diﬀerent
emotional responses, with diﬀerent sensitivity to drugs and
neurological mechanisms. This suggestion is in agreement6 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Summary of the eﬀects of G. sempervirens 5, 7 and 30 CH, and of diazepam 1mg/Kg bw on the main parameters of the LD
test (Panels a and b) and of the OF test (Panels c and d), expressed as percent of the placebo-treated control values. In each experiment
the functional activity of mice was calculated as a percentage with reference to the mean value of the placebo group (control vehicle). The
values from eight experiments (control, placebo and 5 CH), from ﬁve experiments (diazepam), from three experiments (7 CH) and from
two experiments (30 CH) were pooled and analyzed by two-way ANOVA or by the Mann-Whitney test as described in Section 1.
∗P <. 01,
∗∗P <. 001.
with reports showing that anxiolytic treatments do not by
themselves increase exploration in the central zone of the
OF, but that they do decrease the stress-induced inhibition
of exploration behavior [14]. It has been previously reported
that the index of thigmotaxis, assessed by the OF test in
CD1 mice, was not decreased by diazepam (≤5mg/kg)[25].
Others reported anxiolytic eﬀects of diazepam in the OF
paradigm in rat [26, 27], but in mice 1mg/kg [16, 28]o r
1.5mg/kg [29] diazepam did not show signiﬁcant eﬀects
on the time spent in central area of OF. To the best ofEvidence-Based Complementary and Alternative Medicine 7
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Figure 2: Hypothetical mechanism of action of G. sempervirens. Benzodiazepines act by enhancing the inhibitory eﬀects of the
neurotransmitter GABA. The neurosteroid allopregnanolone is produced from progesterone and acts both on the GABA receptor—
at a binding site diﬀerent from benzodiazepines—and on other receptors including the serotonine (5HT) and nicotinic-acetylcholine
receptor, thus reducing the impulse generation in postsynaptic neurons. By ﬁne tuning inhibitory transmission through glycinergic system
and allopregnanolone synthesis [19, 20], G. sempervirens 5 CH may help the nervous system adapt to adverse situations. Due to the
multicomponent nature of G. sempervirens and to our ﬁnding of preferential eﬀects on OF paradigm even at high dilutions/dynamizations,
the existence of other neurosteroid-independent mechanisms may be hypothesized.
our knowledge open ﬁeld behaviors of mice were reduced
by diazepam at doses which may be within the sedative–
hypnotic range [16, 28]. These conﬂicting drives could be
inﬂuenced in various ways by drugs and small diﬀerences in
the experimental conditions may have marked eﬀects on the
outcomes. Ethological models present individual diﬀerences
and variable behavioral baseline levels and this requires
strong care for variable parameters linked to environment,
handling and testing [14].
4.2. Doses and Dilutions. Due to the complexity of the
experimental setting, and in particular the need to use many
animals in each group, in this study we started with a single
dose (potency) of G. sempervirens,n a m e l y5C H ,w h i c hw a s
initially chosen because its dilution is suﬃciently high to be
representative of the homeopathic formulations commonly
used in humans, but also suﬃciently low to contain at least a
few molecules of the purported active principle(s). We made
the assumption that, given a theoretical concentration of the
active principle in the 5 CH solution of 6.5 × 10
−14 moles/l,
its activity on the behavior of mice could be consistent with
a molecular paradigm and with the existence of highly sen-
sitive receptors for this drug in the animals’ central nervous
system, in agreement with other recent evidence [19, 20].
However, the results of the second series of experiments
indicate that the drug may be active also at ultra-high
dilutions/dynamizations. From our data (Figure 1) the 30
CH dilution/dynamization appears to be the most active in
the OF variables, and these apparently paradoxical results
require further conﬁrmation. Indeed, at 30 CH, there is no
active principle in this dilution/dynamization and further
basic evidence will be necessary to make this observation
acceptable. There is growing evidence in the literature that
rodents are responsive to very high dilutions/dynamizations
in immunological [30, 31] and behavioral [11, 32] models. If
conﬁrmed, these eﬀects on mouse behavior would be much
more coherent with the homeopathic paradigm and with
traditional homeopathic medicine than initially expected.
A number of observations—coming from several
research ﬁelds [11, 24, 31–34]—suggest that biologically8 Evidence-Based Complementary and Alternative Medicine
active compounds may indeed have high-dilution eﬀects
which mimics those of lower dilutions (higher doses): in
homeopathy there does not exist linearity or proportionality
between molecular concentration of active principles and
therapeutic eﬀect [33–41].
So far there is no satisfactory or uniting theoretical
explanation for these observations, but recent evidence
seems to point to organization of the solvent water on
a mesoscopic scale: the nano-heterogenous structure of
water can be determined by interactive phenomena such as
coherence [42–44], epitaxy [45, 46], temperature-pressure
processes during strong agitation and formation of colloidal
nanobubbles containing gaseous inclusions of oxygen, nitro-
gen, carbon dioxide, silica and possibly the remedy source
material[46–51].Theseunusualpropertiesofhighdilutions,
which merit further investigation, are potentially relevant
not just to homeopathic pharmaceutical practice, but also to
basic research into cell sensitivity to regulation.
4.3. Hypothetical Mechanisms. A hypothetical diagram
showingthepossibleactionmechanism(s)ofG.sempervirens
is reported in Figure 2. A possible target of G. sempervirens
action at neurological level has been identiﬁed by recent
studies [19, 20], showing that in rat central nervous system
(spinal cord and hippocampus) extremely low doses of this
compound (10
−10 M) and of its active principle gelsemine
enhance the enzymatic production of the neurosteroid
allopregnanolone (5a,3a-tetrahydroprogesterone), an active
stimulator of GABAa and 5HT receptors and therefore of
inhibitory signaling in the central nervous system. This
eﬀect could be due to a speciﬁc interaction at the level
of the glycinergic receptors since this was antagonized by
strychnine. However, since we noted diﬀerences in the action
of conventional and homeopathic anxiolytic-like eﬀects, it
is highly conceivable that the multicomponent nature of the
active principles of G. sempervirens make this compound
able to interact with further receptor or gene expression
systems, which in turn modulate the behavior in novel
environments at more subtle and complex levels.
Beneﬁcial, therapeutical eﬀects of extremely low doses of
agents which are toxic at high doses are deﬁned hormesis.
Recently Calabrese provided a broad range of examples of
neurobiological processes and behavioral eﬀects, including
anxiety models, that exhibit non-linear, biphasic (“reverse-
U”)doseresponsestodrugsandstressors[52,53].According
to some authors, hormesis is not directly related to classical
homeopathy [54] ,b u ti tm a yr e p r e s e n to n eo ft h em a j o r
explanations of the mechanism of action of homeopathic
medicines when utilized in the molecular range of dilu-
tions/dynamizations (approximately <9 CH) [45, 55, 56].
The development of interventions that activate hormetic
signaling pathways in neurons is a promising new approach
for the prevention and treatment of a range of neurological
disorders [57].
5. Conclusions
Taken together, our data suggest that the eﬀects of G.
sempervirens at homeopathic dilutions on unconditioned
mousebehavioralresponsesconcerntheexploratoryattitude
of the animals, a parameter that is better brought out by
the OF test. Mouse behavior in the OF test is aﬀected
by various factors such as individual testing (since mice
are social animals), neophobia (emotional response to a
novel environment) and agoraphobia (being in an exposed
setting from which there is no easy means of escape). In
ourexperimentalconditionsG.sempervirensshowedpositive
eﬀects on these parameters, and the eﬀect observed in
the OF test ﬁts very well with the classical archetype of
the G. sempervirens. Materia Medica, according to which
individuals who respond to this medicine are characterized
by experiencing strong discomfort when confronted with
novelty or unfamiliar situations.
In conclusion, homeopathic doses of G. sempervirens
positively inﬂuence the emotional responses of mice to novel
environments, suggesting an improvement in exploratory
behavior and a decrease in thigmotaxis or neophobia.
The study provides a basic knowledge of the pharmaco-
logical eﬀects of G. sempervirens and can implement the
clinical research on the anxiolytic eﬀect of this drug on
humans, which are based only on empirical knowledge
but not on fundamental evidence supplied by controlled
investigations.
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